Condensed Consolidated Statements of Operations (Unaudited)	3 Months Ended
	Aug. 31, 2020 USD ($) $ / shares shares
Operating expenses:
Research and development	$ 83,507
General and administrative	28,300
Total operating expenses	111,807
Other income (expense):
Interest income	31
Equity in loss of affiliated company	(4,107)
Total other expense, net	(4,076)
Loss before provision for income taxes	(115,883)
Provision for income taxes	0
Net loss	$ (115,883)
Basic loss per common share | $ / shares	$ 0.00
Diluted loss per common share | $ / shares	$ 0.00
Weighted average number of common shares outstanding - basic | shares	47,652,516
Weighted average number of common shares outstanding - diluted | shares	47,652,516